Skip to content

Clinical trials

Phase 1 Acquired Immunodeficiency Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Acquired Immunodeficiency Syndrome Phase: Phase 1 Clear all

459 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20031
20041
20054
20068
20076
200813
200916
201023
201117
201211
20139
201422
201523
201622
201718
201814
201916
202010
202111
202213
202311
20247
20253
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed387
Terminated25
Unknown status19
Recruiting10
Active, not recruiting7
Withdrawn6
Not yet recruiting4
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)116
ViiV Healthcare84
GlaxoSmithKline16
Merck Sharp & Dohme LLC11
International AIDS Vaccine Initiative8
Rockefeller University8
Gilead Sciences7
National Cancer Institute (NCI)6
University of North Carolina, Chapel Hill6
Tibotec Pharmaceuticals, Ireland5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Acquired Immunodeficiency Syndrome459
HIV Infections242
AIDS-Related Complex89
Infections82
Sarcoma, Kaposi21
AIDS-Related Opportunistic Infections17
Cytomegalovirus Infections9
Multiple Acyl Coenzyme A Dehydrogenase Deficiency9
Cytomegalovirus Retinitis7
Pneumonia, Pneumocystis7

Trials

Showing 26 to 50 of 459. Each trial links to its page on Pharma Observatory.

359 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.